Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
autologous umbilical cord blood (1 trial)
Brain Diseases (Phase 2)
Brain Ischemia (Phase 2)
Hypoxia (Phase 2)
Hypoxia-Ischemia, Brain (Phase 2)
Ischemia (Phase 2)
Trials (1 total)
Trial APIs (1 total)